Optic disc melanocytoma is a benign, usually asymptomatic tumor found in the eye, but it can lead to complications like choroidal neovascularization, which can be challenging to distinguish from malignant tumors.
A case study of a 54-year-old man with optic disc melanocytoma showed the need for close monitoring due to growth, prompting treatment with anti-VEGF-A injections after development of neovascular membranes.
Treatment with intravitreal anti-VEGF-A can effectively manage choroidal neovascularization related to optic disc melanocytoma and requires advanced imaging techniques for accurate diagnosis.
* Among 181 AD patients, 14.9% had conjunctivitis at the start, with most seeing improvement by week 16, while 18.7% developed dupilumab-induced blepharoconjunctivitis, primarily as new cases.
* Key risk factors linked to dupilumab-induced blepharoconjunctivitis included having AD on the head and neck, erythroderma, and existing dry eye syndrome, though baseline conjunctivitis severity wasn't a significant factor.